R Kumar1, J A Friedman. 1. Department of Neuroscience and Experimental Therapeutics, Texas A&M Health Science Center College of Medicine, Bryan-College Station, TX 77802, USA. ravi.kumar@mayo.edu
Abstract
BACKGROUND: The first 24 h in the management of aneurysmal subarachnoid hemorrhage (SAH) represent a critical time period for medical intervention. METHODS: We review the current literature and discuss our current clinical practices related to management of acute SAH. RESULTS: A brief objective review of the current evidence along with a subjective overview of the authors practices in the management of aneurysmal subarachnoid hemorrhage in the first 24 h is outlined. CONCLUSIONS: The first 24 h following aneurysmal subarachnoid hemorrhage is a critical time period in which medical and interventional management paradigms continue to evolve.
BACKGROUND: The first 24 h in the management of aneurysmal subarachnoid hemorrhage (SAH) represent a critical time period for medical intervention. METHODS: We review the current literature and discuss our current clinical practices related to management of acute SAH. RESULTS: A brief objective review of the current evidence along with a subjective overview of the authors practices in the management of aneurysmal subarachnoid hemorrhage in the first 24 h is outlined. CONCLUSIONS: The first 24 h following aneurysmal subarachnoid hemorrhage is a critical time period in which medical and interventional management paradigms continue to evolve.
Authors: Frederic P Collignon; Jonathan A Friedman; David G Piepgras; Mark A Pichelmann; Jon I McIver; L Gerard Toussaint; Robyn L McClelland Journal: Neurocrit Care Date: 2004 Impact factor: 3.210
Authors: L Gerard Toussaint; Jonathan A Friedman; Eelco F M Wijdicks; David G Piepgras; Mark A Pichelmann; Jon I McIver; Robyn L McClelland; Douglas A Nichols; Fredric B Meyer; John L D Atkinson Journal: Neurosurgery Date: 2005-07 Impact factor: 4.654
Authors: Martina Stippler; Elizabeth Crago; Elad I Levy; Mary E Kerr; Howard Yonas; Michael B Horowitz; Amin Kassam Journal: J Neurosurg Date: 2006-11 Impact factor: 5.115
Authors: Jonathan A Friedman; Mark A Pichelmann; David G Piepgras; Jon I McIver; L Gerard Toussaint; Robyn L McClelland; Douglas A Nichols; Fredric B Meyer; John L D Atkinson; Eelco F M Wijdicks Journal: Neurosurgery Date: 2003-05 Impact factor: 4.654
Authors: Jan Claassen; An Vu; Kurt T Kreiter; Robert G Kowalski; Evelyn Y Du; Noeleen Ostapkovich; Brian-Fred M Fitzsimmons; E Sander Connolly; Stephan A Mayer Journal: Crit Care Med Date: 2004-03 Impact factor: 7.598
Authors: Jonathan A Friedman; Stephan J Goerss; Fredric B Meyer; David G Piepgras; Mark A Pichelmann; Jon I McIver; L Gerard Toussaint; Robyn L McClelland; Douglas A Nichols; John L D Atkinson; Eelco F M Wijdicks Journal: J Neurosurg Date: 2002-08 Impact factor: 5.115
Authors: Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock Journal: Lancet Date: 2005 Sep 3-9 Impact factor: 79.321